Kwality Pharmaceuticals has successfully obtained product approval in South Africa (SAHPRA) for its prominent oncology oral solid dosage (OSD) product, Tamoxifen 20mg Tablet, through a site transfer process.
This approval is a significant achievement in expanding the availability of this critical therapeutic, which plays a vital role in the treatment of hormone receptor-positive breast cancer. It reflects its ongoing commitment to providing high-quality, accessible oncology treatments to patients in key markets. This approval further strengthens its presence in the High Regulated and global oncology market.
Kwality Pharmaceuticals (formerly Kwality Pharmaceuticals) is a pharmaceutical formation company.
